CRGX(Delisted)
CARGO Therapeutics (CRGX) Stock Statistics, Valuation & Financial Metrics
Total Valuation
CARGO Therapeutics market cap is -- and enterprise value is --.
Share Statistics
CARGO Therapeutics has 48.36M shares outstanding, with a free float of 35.61M.
Valuation Ratios
CARGO Therapeutics's PE ratio is --, PB ratio is --, and PS ratio is --, showing whether the stock looks expensive or cheap.
Solvency
CARGO Therapeutics debt-to-equity ratio is -- and debt-to-assets ratio is 0.08.
Liquidity
CARGO Therapeutics's current ratio is 12.37, quick ratio is 12.37, and cash ratio is --, showing its short-term liquidity position.
Return on Capital
CARGO Therapeutics's ROE is --, ROA is --, and ROIC is --, showing its return on capital profile.
Profitability
CARGO Therapeutics gross margin is --, operating margin is --, and net margin is --.
Operating Efficiency
CARGO Therapeutics's asset turnover is --, inventory turnover is --, and receivables turnover is --, indicating its operating efficiency.
Income Statement
CARGO Therapeutics's revenue is --, gross profit is --, net income is --, and EBITDA is --.
Balance Sheet
CARGO Therapeutics's total debt is --, net debt is --, total equity is --, and cash is --.
Cash Flow Statement
CARGO Therapeutics's operating cash flow is -189.59M, free cash flow is -192.12M, and CapEx is -2.53M.
Dividends & Yields
CARGO Therapeutics dividend yield is --, with a payout ratio of -- and dividend per share of --.
Analyst Rating
CARGO Therapeutics's latest analyst rating is Unrate, with an analyst target price of --.
Company Info
A clinical-stage biotechnology company developing cancer therapies
Per Share Metrics
CARGO Therapeutics's EPS is --, book value per share is --, and free cash flow per share is --.
